Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes

Many papers have previously suggested an association between the long-term use of statins (e.g., simvastatin/Zocor and atorvastatin/Lipitor) or nonsteroidal anti-inflammatory drugs (NSAIDs, like aspirin), the risk of prostate cancer diagnosis, and the overall survival of men diagnosed with prostate cancer.

A recent study has now reported data from a retrospective analysis of NSAID and statin use among 7,042 men who underwent radical prostatectomy or radiotherapy for prostate cancer between 1990 and 2003.

The authors conclude that, in this population of men treated for prostate cancer, the “ever-use” of either a statin and/or an NSAID was associated with a reduced risk of ACM. They also note that this study “highlights the importance of multidisciplinary survivorship care for men with prostate cancer.”